Citations

Citations to this article as recorded by  

• Bifidobacterium bifidum BGN4 fractions ameliorate palmitic acid-induced hepatocyte ferroptosis by inhibiting SREBP1-CYP2E1 pathway
  Guangkui Bu, Gang Chen, Juan Li, Dan Wu, Jiangtao Liao
  Journal of Investigative Medicine.2024; 72(1): 67.     CrossRef
• Docosahexaenoic acid (DHA) alleviates hepatic lipid accumulation by regulating mitochondrial quality control through ERK signaling pathway in grass carp (Ctenopharyngodon idellus)
  Chenchen Bian, Shanghong Ji, Caihong Zeng, Jian Sun, Gen Kaneko, Hong Ji
  Aquaculture.2024; 579: 740209.     CrossRef
• Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study
  Lubo Shi, Xiaoduo Liu, Enze Li, Shutian Zhang, Anni Zhou
  Journal of Clinical Lipidology.2024;[Epub]     CrossRef
• Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity
  Oladayo Emmanuel Apalowo, Grace Adeola Adegoye, Tolulope Mobolaji Obuotor
  Current Issues in Molecular Biology.2024; 46(3): 1810.     CrossRef
• Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
  Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yu Zhang, Qian Cao, Mengque Xu
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota
  Wenkai Zhang, Longhui Yu, Qinru Yang, Jinfeng Zhang, Wenjing Wang, Xinru Hu, Jingen Li, Guodong Zheng
  Phytomedicine.2024; 127: 155478.     CrossRef
• Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
  Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
  Gut Microbes.2024;[Epub]     CrossRef
• Prospect of research on anti-atherosclerosis effect of main components of traditional Chinese medicine Yiqi Huoxue Huatan recipe through gut microbiota: A review
  Hongtao Huang, Hanjun Zhao, Lv Wenqing, Feiyue Xu, Xiaolong Wang, Yili Yao, Yu Huang
  Medicine.2024; 103(5): e37104.     CrossRef
• Polysaccharides from Eucommia ulmoides Oliv. Leaves Alleviate Acute Alcoholic Liver Injury by Modulating the Microbiota–Gut–Liver Axis in Mice
  Yingzhi Li, Huimei Wang, Xueping Leng, Jiaming Gao, Chang Li, Danfei Huang
  Foods.2024; 13(7): 1089.     CrossRef
• Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
  Feng Zhang, Jiaming Ju, Hongtao Diao, Jinglun Song, Yu bian, Baofeng Yang
  British Journal of Pharmacology.2024;[Epub]     CrossRef
• Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
  Dongliang Chen, Yuanfei Wang, Jianmei Yang, Wanyi Ou, Guiru Lin, Ze Zeng, Xiaomin Lu, Zumin Chen, Lili Zou, Yaling Tian, Aiping Wu, Shelley E. Keating, Qinhe Yang, Chenli Lin, Yinji Liang
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: insights from microbiome and metabolomics
  Xinyi Cheng, Yang Hu, Jun Kuang, Xiaoquan Guo, Huabin Cao, Huansheng Wu, Guoliang Hu, Yu Zhuang
  Poultry Science.2024; 103(8): 103968.     CrossRef
• Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
  Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei
  Biomedicines.2024; 12(7): 1398.     CrossRef
• The molecular and network mechanisms of antilipidemic potential effects of Ganfule capsules in nonalcoholic fatty liver disease
  Yu Pan, Liya Qiao, Yunkun Zhang, Suren R. Sooranna, Danna Huang, Min Ou, Fei Xu, Lu Chen, Dan Huang
  Heliyon.2024; 10(14): e34297.     CrossRef
• Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators
  Lara Pires, Ana M. González-Paramás, Sandrina A. Heleno, Ricardo C. Calhelha
  Antibiotics.2024; 13(8): 720.     CrossRef
• Polysaccharide-mediated modulation of gut microbiota in the treatment of liver diseases: Promising approach with significant challenges
  Yang Yang, Guifang Fan, Jianhang Lan, Xin Li, Xiaojiaoyang Li, Runping Liu
  International Journal of Biological Macromolecules.2024; 280: 135566.     CrossRef
• Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease
  Huafeng Chen, Shengzhe Yan, Qianru Xiang, Jiamin Liang, Xuejian Deng, Wanqin He, Yanzhen Cheng, Li Yang
  BMC Complementary Medicine and Therapies.2024;[Epub]     CrossRef
• Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism
  Xu Dong, Yu-Ting Xiong, Tingting He, Congyang Zheng, Junjie Li, Yingjie Zhuang, Yingjie Xu, Ye Xiu, Zhixin Wu, Xiaomei Zhao, Xiaohe Xiao, Zhaofang Bai, Lili Gao
  Genes & Nutrition.2024;[Epub]     CrossRef
• Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
  Junyi Chen, Shuzhan Yang, Hanxia Luo, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Feiyue Chen, Danning Xu, Nan Cao
  International Immunopharmacology.2024; 141: 113014.     CrossRef
• Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
  Hao CHEN, Yang ZHOU, Haiping HAO, Jing XIONG
  Chinese Journal of Natural Medicines.2024; 22(8): 724.     CrossRef
• Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future
  Shehzeen Noor, Shaukat Ali, Muhammad Summer, Anfah Riaz, Laiba Nazakat, Aqsa
  Probiotics and Antimicrobial Proteins.2024;[Epub]     CrossRef
• Danshen polysaccharides alleviate AFB1 induced Jejunal injury
  Lu Zhang, Xincheng Gong, Shijia Zhang, Chanchan Cui, Qiongyi Zhang, Xiao Wang, Wanyu Shi, Yongzhan Bao
  Ecotoxicology and Environmental Safety.2024; 285: 117115.     CrossRef
• Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
  Hui Han, Yi Jiang, Mengyu Wang, Mebratu Melaku, Lei Liu, Yong Zhao, Nadia Everaert, Bao Yi, Hongfu Zhang
  Critical Reviews in Food Science and Nutrition.2023; 63(12): 1689.     CrossRef
• Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance
  Clement Agboyibor, Jianshu Dong, Clement Yaw Effah, Emmanuel Kwateng Drokow, Maxwell Ampomah-Wireko, Waqar Pervaiz, Augustina Sangmor, Xinli Ma, Jian Li, Hong-Min Liu, Peng Zhang
  Biomedicine & Pharmacotherapy.2023; 157: 113934.     CrossRef
• Salvia miltiorrhiza polysaccharides alleviate florfenicol-induced inflammation and oxidative stress in chick livers by regulating phagosome signaling pathway
  Xiao Wang, Wei Liu, Di Zhang, Yulan Jiao, Qianhui Zhao, Ying Liu, Wanyu Shi, Yongzhan Bao
  Ecotoxicology and Environmental Safety.2023; 249: 114428.     CrossRef
• Preparation methods, structural characteristics, and biological activity of polysaccharides from Salvia miltiorrhiza: A review
  Yuanyuan Li, Xin Zhang, Yining Li, Pei Yang, Zhiyuan Zhang, Hang Wu, Lihao Zhu, Yuhong Liu
  Journal of Ethnopharmacology.2023; 305: 116090.     CrossRef
• The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial
  Dengcheng Hui, Lu Liu, Nisma Lena Bahaji Azami, Jingru Song, Yanping Huang, Wan Xu, Chao Wu, Dong Xie, Yulang Jiang, Yanqin Bian, Mingyu Sun
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
  Xiaoyu Huang, Yi Yang, Xueli Li, Xiaoya Zhu, Dan Lin, Yueran Ma, Min Zhou, Xiangyi Cui, Bingyu Zhang, Dongmei Dang, Yuhong Lü, Changwu Yue
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Polysaccharides from Ostrea rivularis rebuild the balance of gut microbiota to ameliorate non-alcoholic fatty liver disease in ApoE−/− mice
  Lijun Zhu, Mingmei Xiao, Jigang Luo, Shijie Li, Wenting Liu, Jinchuan Wu, Zhuoyue Song
  International Journal of Biological Macromolecules.2023; 235: 123853.     CrossRef
• Improvement of Inflammation, Diabetes, and Obesity by Forest Product-Derived Polysaccharides through the Human Intestinal Microbiota
  Seong-woo MYEONG, Yong Ju LEE, Do Hyun KIM, Tae-Jong KIM
  Journal of the Korean Wood Science and Technology.2023; 51(5): 358.     CrossRef
• Recent developments in Salvia miltiorrhiza polysaccharides: Isolation, purification, structural characteristics and biological activities
  Lei Luo, Juan Xue, Zheng Shao, Zhang Zhou, Wenqian Tang, Jinxin Liu, Hongfei Hu, Fan Yang
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease
  Huihui Lv, Feiyue Tao, Lingling Peng, Shufang Chen, Zhongyue Ren, Jiahui Chen, Bo Yu, Hua Wei, Cuixiang Wan
  Nutrients.2023; 15(6): 1355.     CrossRef
• Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro
  Jin Chen, Guoping Zhu, Wenbo Xiao, Xiaosong Huang, Kewu Wang, Yi Zong
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 779.     CrossRef
• Managing metabolic diseases: The roles and therapeutic prospects of herb-derived polysaccharides
  Xinmei Xu, Lijie Wang, Kun Zhang, Yi Zhang, Gang Fan
  Biomedicine & Pharmacotherapy.2023; 161: 114538.     CrossRef
• Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits
  Huan Wang, Cuicui Ma, Yan Li, Lei Zhang, lima A, Chengcong Yang, Feiyan Zhao, Haifeng Han, Dongyang Shang, Fan Yang, Yuying Zhang, Heping Zhang, Zhihong Sun, Ruifang Guo, Yuan Pin Hung
  Microbiology Spectrum.2023;[Epub]     CrossRef
• Sea cucumber sulfated polysaccharides and Lactobacillus gasseri synergistically ameliorate the overweight induced by altered gut microbiota in mice
  Zhengqi Liu, Chunqing Ai, Xinping Lin, Xiaoming Guo, Shuang Song, Beiwei Zhu
  Food & Function.2023; 14(9): 4106.     CrossRef
• Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats
  Xingjian Wen, Hejing Liu, Xiaoling Luo, Li Lui, Jiuyu Fan, Yajing Xing, Jia Wang, Xingfang Qiao, Na Li, Guixue Wang
  Frontiers in Microbiology.2023;[Epub]     CrossRef
• Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
  Ling Ye, Shicheng Fan, Pengfei Zhao, Chenghua Wu, Menghua Liu, Shuang Hu, Peng Wang, Hongyu Wang, Huichang Bi
  Acta Pharmaceutica Sinica B.2023; 13(9): 3598.     CrossRef
• α‐Lactalbumin Peptide Asp‐Gln‐Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids‐Treated HepG2 Cells and High‐Fat Diet‐Induced NAFLD Mice by Activating the PPARα Pathway
  Haoran Chen, Yanfeng Ma, Xiaofen Qi, Jianjun Tian, Ying Ma, Tianjiao Niu
  Molecular Nutrition & Food Research.2023;[Epub]     CrossRef
• Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′‐monophosphate‐activated protein kinase pathway and reshaping gut microbiota
  Chao Han, Zongshuo Li, Ruiying Liu, Zihan Zhao, Yu Wang, Xuli Zuo, Yushi Zhang, Zeyu Geng, Houyu Huang, Xiuzhen Pan, Weidong Li
  Journal of the Science of Food and Agriculture.2023; 103(15): 7721.     CrossRef
• Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
  Qin Guo, Yun Li, Xin Dai, Bangmao Wang, Jie Zhang, Hailong Cao
  Nutrients.2023; 15(17): 3722.     CrossRef
• Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
  Alejandra Mijangos-Trejo, Natalia Nuño-Lambarri, Varenka Barbero-Becerra, Misael Uribe-Esquivel, Paulina Vidal-Cevallos, Norberto Chávez-Tapia
  International Journal of Molecular Sciences.2023; 24(19): 14918.     CrossRef
• Repair Effect and Mechanism of Electrospinning Nanocomposite Material with Gelatin-Bletilla Striata Gum/Salvia Miltiorrhiza on Orthopedic Refractory Wounds
  Geliang Hu, Ming Deng, Yonggang Ma, Jianghua Ming
  Journal of Biomedical Nanotechnology.2023; 19(10): 1783.     CrossRef
• Characterisation and skin protection activities of polysaccharides from Schnabelia terniflora
  Ying Zhao, Yixian Liu, Huoxiang Zhou, Wei Guo, Weidong Wang, Huiping Chen
  Natural Product Research.2023; : 1.     CrossRef
• Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study
  Hong Pan, Baocheng Liu, Xin Luo, Xinxin Shen, Jijia Sun, An Zhang
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review
  Henan Zhang, Fuchun Jiang, Jinsong Zhang, Wenhan Wang, Lin Li, Jingkun Yan
  International Journal of Biological Macromolecules.2022; 204: 169.     CrossRef
• Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
  Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao
  Bioengineered.2022; 13(3): 5216.     CrossRef
• Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
  Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Do
  Biomedicines.2022; 10(3): 550.     CrossRef
• Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Yu Hu, Zhen Ye, Yingqi She, Linzhen Li, Mingquan Wu, Kaihua Qin, Yuzheng Li, Haiqing He, Zhipeng Hu, Maoyi Yang, Fating Lu, Qiaobo Ye
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
  Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets
  Jie Liu, Yun Shi, Daiyin Peng, Lei Wang, Nianjun Yu, Guokai Wang, Weidong Chen
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
  Yijing Ren, Siyue Li, Zixuan Song, Qiuping Luo, Yingying Zhang, Hao Wang
  Nutrients.2022; 14(11): 2303.     CrossRef
• Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis
  Yuhang Li, Juxiong Liu, Bojian Ye, Yueyao Cui, Ruiqi Geng, Shu Liu, Yufei Zhang, Wenjin Guo, Shoupeng Fu
  Journal of Agricultural and Food Chemistry.2022; 70(34): 10620.     CrossRef
• Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
  Mingmei Shao, Yifei Lu, Hongjiao Xiang, Junmin Wang, Guang Ji, Tao Wu
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• The chemistry and efficacy benefits of polysaccharides from Atractylodes macrocephala Koidz
  Congying Liu, Shengguang Wang, Zedong Xiang, Tong Xu, Mengyuan He, Qing Xue, Huaying Song, Peng Gao, Zhufeng Cong
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies
  Min-Han Chi, Jung Chao, Chien-Yu Ko, Shyh-Shyun Huang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Three water soluble polysaccharides with anti-inflammatory activities from Selaginella uncinata (Desv.) Spring
  Haochen Hui, Meng Gao, Xuerong Zhao, Lianhong Yin, Lina Xu, Lili Li, Jinyong Peng
  International Journal of Biological Macromolecules.2022; 222: 1983.     CrossRef
• Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
  Xiang Chen, Menghan Liu, Jun Tang, Ning Wang, Yibin Feng, Haotian Ma
  International Journal of Molecular Sciences.2022; 23(19): 11710.     CrossRef
• Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet
  Sai Wang, Xin-Yu Li, Hong-Fang Ji, Liang Shen
  Life Sciences.2022; 310: 121110.     CrossRef
• Structural Alteration of Gut Microbiota During the Amelioration of Chronic Psychological Stress-Aggravated Diabetes-Associated Cognitive Decline by a Traditional Chinese Herbal Formula, ZiBu PiYin Recipe
  Wen Zhou, Libin Zhan, Huiying Xu, Lijing Zhang
  Journal of Alzheimer's Disease.2022; 90(4): 1465.     CrossRef
• Bacillus amyloliquefaciens SC06 in the diet improves egg quality of hens by altering intestinal microbiota and the effect is diminished by antimicrobial peptide
  Shujie Xu, Fei Wang, Peng Zou, Xiang Li, Qian Jin, Qi Wang, Baikui Wang, Yuanhao Zhou, Li Tang, Dongyou Yu, Weifen Li
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Effect of stigma maydis polysaccharide on the gut microbiota and transcriptome of VPA induced autism model rats
  Xiaolei Yang, Jiyuan Li, Yang Zhou, Ning Zhang, Jicheng Liu
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism
  Zi-Li Ai, Xian Zhang, Wei Ge, You-Bao Zhong, Hai-Yan Wang, Zheng-Yun Zuo, Duan-Yong Liu
  World Journal of Gastroenterology.2022; 28(43): 6131.     CrossRef
• Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
  Fang Xie, Hang-fei Xu, Jing Zhang, Xiao-ni Liu, Bu-xin Kou, Meng-yin Cai, Jing Wu, Jin-ling Dong, Qing-hua Meng, Yi Wang, Dexi Chen, Yang Zhang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Structural elucidation and anti-nonalcoholic fatty liver disease activity of Polygonatum cyrtonema Hua polysaccharide
  Wei Liu, Taili Shao, Lei Tian, Zhengrui Ren, Lan Gao, Zhiyan Tang, Zheng Fang, Pingchuan Yuan, Chunyan Liu, Jikun Li, Guodong Wang, Jun Han
  Food & Function.2022; 13(24): 12883.     CrossRef
• The protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice via mediating the FXR/LXRα pathway
  Shaotong Ma, Xinyi Pang, Shuhua Tian, Jing Sun, Qiaobin Hu, Xiangfei Li, Yingjian Lu
  Food & Function.2022; 13(24): 12966.     CrossRef
• Gut Microbiota is A Crucial Bridge Mediating the Pharmacological Effect of Labiatae Traditional Chinese Medicine
  Yanan Yang, Fang Zhang, Jiaqi Yu, Chongming Wu
  Diseases and Research.2022; 2(1): 13.     CrossRef
• Suppression of obesity and inflammation by polysaccharide from sporoderm-broken spore of Ganoderma lucidum via gut microbiota regulation
  Tingting Sang, Chengjie Guo, Dandan Guo, Jianjun Wu, Yujie Wang, Ying Wang, Jiajun Chen, Chaojie Chen, Kaikai Wu, Kun Na, Kang Li, Liu Fang, Cuiling Guo, Xingya Wang
  Carbohydrate Polymers.2021; 256: 117594.     CrossRef
• Annual review of LSD1/KDM1A inhibitors in 2020
  Dong-Jun Fu, Jun Li, Bin Yu
  European Journal of Medicinal Chemistry.2021; 214: 113254.     CrossRef
• Diet-Regulating Microbiota and Host Immune System in Liver Disease
  Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min
  International Journal of Molecular Sciences.2021; 22(12): 6326.     CrossRef
• Lactobacillus johnsonii BS15 combined with abdominal massage on intestinal permeability in rats with nonalcoholic fatty liver and cell biofilm repair
  Wei Zhang, Huanan Li, Na Zhao, Xiongfei Luo, Siwen Liu, an Bao, Yingying Chen, Haiteng Wang, Junshi Wang, Jingui Wang
  Bioengineered.2021; 12(1): 6354.     CrossRef
• Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
  Hang-Yu Li, Dan-Dan Zhou, Ren-You Gan, Si-Yu Huang, Cai-Ning Zhao, Ao Shang, Xiao-Yu Xu, Hua-Bin Li
  Nutrients.2021; 13(9): 3211.     CrossRef
• Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis
  Guangqing Cheng, Xiaoni Yan, Fengmeng Wang, Chao Chen, Muhammad Wasim Khan
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes
  Abdul Rahman Conteh, Ruixue Huang
  Toxicology Research.2020; 9(4): 569.     CrossRef
• MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
  Shu Fang, Jie Feng, Hongbin Zhang, Ping Li, Yudan Zhang, Yanmei Zeng, Yingying Cai, Xiaochun Lin, Yaoming Xue, Meiping Guan
  Adipocyte.2020; 9(1): 179.     CrossRef
• Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
  Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Probiyotiklerin Kolon Mikrobiyotasına Etkileri: Güncel Çalışmalar
  Çağlar GÖKIRMAKLI, Zeynep SEYDİM
  Journal of Biotechnology and Strategic Health Research.2020; 4(3): 212.     CrossRef